No Data
No Data
No Data
No Data
No Data
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced
GlobeNewswireApr 16 07:00 ET
Investors Give AxoGen, Inc. (NASDAQ:AXGN) Shares A 28% Hiding
The AxoGen, Inc. (NASDAQ:AXGN) share price has softened a substantial 28% over the previous 30 days, handing back much of the gains the stock has made lately.
Simply Wall StMar 17 08:51 ET
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)
Yahoo FinanceMar 8 23:55 ET
AxoGen(AXGN.US) Officer Sells US$319.89K in Common Stocks
$AxoGen(AXGN.US)$ Officer Donovan Michael Patrick sold 36,310 shares of Common Stocks on Mar 7, 2024 at an average price of $8.81 for a total value of $319.89K.Source: Announcement What is statement o
moomoo NewsMar 8 18:15 ET
AxoGen(AXGN.US) Director Sells US$225K in Common Stocks
$AxoGen(AXGN.US)$ Director Freitag Gregory Gene sold 25,000 shares of Common Stocks on Mar 7, 2024 at an average price of $9 for a total value of $225K.Source: Announcement What is statement of change
moomoo NewsMar 8 18:15 ET
Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing
Michael Patrick Donovan, Vice President, Operations, on March 07, 2024, sold 36,310 shares in Axogen (AXGN) for $319,891. Following the Form 4 filing with the SEC, Donovan has control over a total of
MT NewswiresMar 8 17:43 ET
No Data
No Data